Nanjing MilestonePharma Co. Ltd. – FDA Inspection, Aug 1, 2023

Record Details

This FDA Inspection record concerns Nanjing MilestonePharma Co. Ltd., with an inspection on August 1, 2023, issued by the Office of Inspections and Investigations.

Company: Nanjing MilestonePharma Co. Ltd.
Inspection Date: August 1, 2023
Office: Office of Inspections and Investigations
People: Kevin P. Regan (FDA Associated Person)
Timothy H. Vo (Company Rep)

View Company Profile

ID · 8ff2797e-5772-4149-8196-732e7ccb171c

Inspection Facts

Voluntary Action Indicated (VAI)

Objectionable conditions were found, but FDA is not prepared to take or recommend regulatory action.

Inspection number: 1215544
FDA center: Human Drugs
Outcome: Form 483 issued

FDA Citations

21 CFR 211.160(a)Deviations from laboratory control requirements

Full citation text and observation details available on the Dashboard.

Discuss this record with AI

KeyPedia

ChatGPT

Claude

Perplexity

Grok

Copilot

Document or profile

One record shows the event. A profile shows the pattern.

Buy this document for the source file and details behind this single event.

Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.

Explore Nanjing MilestonePharma Co. Ltd.

FDA Inspection

Nanjing MilestonePharma Co. Ltd.August 1, 2023